CLPT Q1 2021 Earnings — ClearPoint Neuro, Inc. Revenue & Financial Results | Market Cap Arena

CLPTClearPoint Neuro, Inc.

$340M

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$4M+29.3% YoY

Gross Profit

$3M64.9% margin

Operating Income

-$2M-54.1% margin

Net Income

-$3M-63.0% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+8.4%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$320,000

Balance Sheet

Total Assets

$74M

Total Liabilities

$30M

Stockholders' Equity

$44M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+29.3%
Gross Profit	$3M	$2M	+19.7%
Operating Income	-$2M	-$1M	-80.4%
Net Income	-$3M	-$2M	-23.5%

Revenue Segments

Biologics and Drug Delivery Revenue

$2M79%

Capital Equipment and Software Revenue

$453,00021%